In an August 8 interim report, radiation therapy clinic software provider RaySearch Laboratories posted increased net sales of 636.6 million Swedish kronor ($66.5 million U.S.) for the half-year 2025, at a slightly lower operating profit of 111.2 million Swedish kronor ($11.6 million).
For the period (January-June), the Stockholm, Sweden-based company also posted a lower profit after tax of 87.6 million Swedish kronor ($9.2 million), a 11% decrease from the same period last year, while net sales were up 10.5%.
For the second quarter (April-June), RaySearch reported order intake amounting to 241.2 million Swedish kronor ($25.2 million), a 17% decrease over the same period in 2024. Net sales amounted to 304.9 million Swedish kronor ($31.9 million), down 4.4%.
The company also highlighted significant events during the second quarter. They include the following:
- AKSM/Oncology selected RayCare oncology information system and RayStation treatment planning system for Advanced Radiation Therapeutics (ART), a new freestanding, multidisciplinary cancer center in partnership with Urology Associates in San Luis Obispo, CA, and Dignity Health.
- RaySearch and Radiology Oncology Systems announced a strategic partnership with a focus on the integration of refurbished linear accelerators with advanced software.
- Odense University Hospital in Denmark placed an order and is increasing the level of automation with the RayStation treatment planning system, according to RaySearch.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
